Mizuho raises UnitedHealth price target to $460
Mizuho analyst Ann Hynes maintained an Outperform rating on UnitedHealth Group and raised the price target to $460 from $440, signaling continued confidence in the stock.
*this image is generated using AI for illustrative purposes only.
Mizuho analyst Ann Hynes has maintained an Outperform rating on UnitedHealth Group and increased the price target to $460 from $440. The adjustment reflects a revised outlook on the healthcare company's stock performance.
Rating and Price Action
The research note reaffirms the positive stance on UnitedHealth Group shares. The new price target of $460 represents an increase from the previous target of $440.
| Metric | Value |
|---|---|
| Rating | Outperform |
| Previous Price Target | $440 |
| New Price Target | $460 |
What specific factors drove Mizuho to revise UnitedHealth Group's price target upward?
How might this rating adjustment influence investor sentiment towards the healthcare sector?
What are the potential risks that could hinder UnitedHealth Group from reaching the new price target?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
